An antagonist of α2-adrenergic and imidazoline I1 and I2 receptors
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Idazoxan (hydrochloride)

Item No. 41310

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole, monohydrochloride
CAS Number
79944-56-2
Synonyms
  • RX 781094
Molecular Formula
C11H12N2O2 • HCl
Formula Weight
240.7
Purity
≥95%
Formulation (Request formulation change)
A solid
Solubility(Learn about Variance in Solubility)
DMSO: Soluble: ≥ 10 mg/mlEthanol: Sparingly soluble: 1-10 mg/mlPBS (pH 7.2): Soluble: ≥ 10 mg/ml
SMILES
C1(OCC(C2=NCCN2)O3)=C3C=CC=C1.Cl
InChi Code
InChI=1S/C11H12N2O2.ClH/c1-2-4-9-8(3-1)14-7-10(15-9)11-12-5-6-13-11;/h1-4,10H,5-7H2,(H,12,13);1H
InChi Key
MYUBYOVCLMEAOH-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $60

    Add

    10 mg

    $102

    Add

    25 mg

    $179

    Add
    Product Description

    Idazoxan is an antagonist of α2-adrenergic receptors (α2-ARs) and imidazoline I1 and I2 receptors (IC50s = 69, 66, and 61 nM, respectively).1 It selectively binds to α2A- and α2C-ARs over α2B-ARs (Kds = 67, 69, and 407 nM, respectively), as well as α2-ARs over α1-ARs (IC50s = 0.7 and 4,000 µM, respectively).2,3 Idazoxan (0.1-5 mg/kg) increases mean arterial pressure and decreases heart rate in rabbits.3 It reverses the anti-hyperalgesic activity of 2-BFI (Item No. 42338) in rat models of inflammatory and neuropathic pain and the antidepressant-like activity of 2-BFI in the tail suspension test in mice.4,5 Idazoxan (7.5 and 10 mg/kg) reduces L-DOPA-induced dyskinesia in a cynomolgus monkey model of MPTP-induced Parkinson’s disease.6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Flamez, A., De Backer, J.P., Czerwiec, E., et al. Pharmacological characterization of I1 and I2 imidazoline receptors in human striatum. Neurochem. Int. 30(1), 25-29 (1997).

    2. Proudman, R.G.W., Pupo, A.S., and Baker, J.G. The affinity and selectivity of α-adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D-adrenoceptors. Pharmacol. Res. Perspect. 8(4), e00602 (2020).

    3. Hannah, J.A.M., Hamilton, C.A., and Reid, J.L. RX781094, a new potent α2 adrenoceptor antagonist. In vivo and in vitro studies in the rabbit. Naunyn Schmiedebergs Arch. Pharmacol. 322(3), 221-227 (1983).

    4. Li, J.-X., Thorn, D.A., Qiu, Y., et al. Antihyperalgesic effects of imidazoline I2 receptor ligands in rat models of inflammatory and neuropathic pain. Br. J. Pharmacol. 171(6), 1580-1590 (2014).

    5. Tonello, R., Villarinho, J.G., da Silva Sant'Anna, G., et al. The potential antidepressant-like effect of imidazoline I2 ligand 2-BFI in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 37(1), 15-21 (2012).

    6. Grondin, R., Tahar, A.H., Doan, V.D., et al. Noradrenoceptor antagonism with idazoxan improves L-dopa-induced dyskinesias in MPTP monkeys. Naunyn Schmiedebergs Arch. Pharmacol. 361(2), 181-186 (2000).